Maker of Hepatitis C Drug Strikes Deal on Generics for Poor Countries
Follow on Twitter @GoAfricaNetwork NEW DELHI — The maker of one of the costliest drugs in the world announced on Monday that it had struck agreements with seven Indian generic drug makers to sell lower-cost versions of its $1,000-a-pill Hepatitis C drug in poorer countries. Gilead Sciences, the California-based drug maker, also said it will begin […]
Maker of Hepatitis C Drug Strikes Deal on Generics for Poor Countries Read More »